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a b s t r a c t
The events culminating in ovulation are controlled by the cyclical actions of hormones such as Follical
Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The secondary messenger, cyclic AMP (cAMP)
conveys the intracellular activity of these hormones. It is well established that a family of transcription
factors facilitate cAMP mediated gene expression, yet it remains unknown how these factors directly
affect ovulation. One of these factors, Inducible cAMP Early Repressor (ICER) has been implicated in the
transcriptional regulation of cAMP inducible genes during folliculogenesis and ovulation. In order to
better determine the role of ICER in ovarian function we have identified novel targets using a genome-
wide approach. Using a modification of the chromatin immunoprecipitation (ChIP) assay we directly
cloned and sequenced the immunoprecipitated ICER-associated DNAs from an immortalized mouse
granulose cell line (GRMO2). The analysis of the immunoprecipitated DNA fragments has revealed that
ICER's binding to DNA has the following distribution; 16% within the promoter region, 31% within an
intron, 14% were not within a gene, 6% were within 20 kb of a promoter and 3% were within the 30 end of
genes.
© 2016 Elsevier Inc. All rights reserved.
1. Introduction
To date, there is no well-established, comprehensive model
which characterizes the signaling events culminating in ovulation.
Follicular development and subsequent ovulation is dictated in part
by the follicle stimulating hormone (FSH) and luteinizing hormone
(LH) and their affects on gene expression. A critical component of
the intracellular activity of these two hormones is relayed by the
second messenger cAMP [1]. Numerous genes expressed in the
ovary are regulated by cAMP as a consequence of gonadotropin
signaling [2]. The expression of cAMP-responsive genes is mediated
by a large family of transcription factors of which CREM has been
well characterized [3,4]. CREM is unique among the other CRE
binding transcription factors in that an internal promoter exists and
codes for an isoform that acts to regulate its expression [5]. This
induced isoform, ICER (Inducible cAMP Early Repressor), serves as a
dominant negative regulator of CREM expression. ICER is one of the
smallest transcription factors to date, and represses the
transcription of cAMP responsive genes by binding as a homodimer
or heterodimer with other CRE-binding family members. The ICER
protein possesses DNA-binding and dimerization domains while
lacking the kinase-inducible and transactivation domains. ICER is
characterized by a greater affinity to CRE-sequences than other
transcription factors and thus makes ICER a powerful repressor. We
and others have implicated ICER's role in regulating normal ovarian
function [6] through its repression of inhibin alpha, aromatase
Cyp19a1, and cyclin D2 [7e10]. An unbiased range of targets for
ICER has yet to be explored. Since ICER negatively regulates the
transcription of cAMP responsive genes by binding to a CRE, we
performed a global analysis mapping the binding distribution of
ICER along the entire mouse genome using a modification of the
ChIP assay. This assay allowed us to clone and directly identify
candidate genes that ICER could potentially regulate by physically
binding to CREs present within their sequences. This analysis will
lead to the identification of pathways involved in ovulation,
potentially regulated by ICER pathways or by the cAMP pathway
in general. In these report we identified a number of novel
binding sites and our results support the role of ICER as an integral
player in the signaling machinery responsible for normal ovarian
function.
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2. Materials & methods
2.1. Reagents
AmpliTaq Gold DNA Polymerase with Buffer II and MgCl2 solu-
tion for general PCR reactions were purchased from Applied Bio-
systems, Foster City, CA. Restriction enzymes and modification
enzymes were purchased from New England BioLabs, Beverly, MA.
TOPO TA Cloning Kit (with pCR2.1-TOPO vector pCRII-TOPO vector)
with One Shot Chemically Competent E. coli, TOPO Shotgun Sub-
cloning Kit and LipofectAMINE 2000 reagent were purchased from
Invitrogen, Carlsbad, CA. Oligonucleotides for PCR based reactions
were purchased from The Molecular Resource Facility UMDNJ,
Newark, NJ. Cell culture media was purchased from Cellgro by
Mediatech, Inc., Herndon, VA. Except Fetal bovine serum was pur-
chased from Hyclone, UT. Insulin-Transferrin-Sodium Selenite
media supplement was purchased from Sigma, St. Louis, MO.
2.2. Immortalized mouse granulosa cell line (GRMO2)
GRMO2 cells [11] (N.V. Innogenetics, Ghent, Belgium) were
cultured in DMEM-F12, supplemented with Insulin-Transferrin-
Sodium Selenite media supplement and 2% FBS in a humidified
incubator at 37 C and 5% CO2. GRMO2 were transiently transfected
using LipofectAMINE 2000 Reagent (Invitrogen, Carlsbad, CA).
2.3. Antibodies
The anti-ICER polyclonal antibody was raised against bacterially
purified ICER-IIg and previously characterized [5,12]. This antibody
has been shown to cross react with other CREM isoforms and ubiq-
uitinated forms of ICER and does not cross react with CREB [5,12].
2.4. Chromatin immunoprecipitation (ChIP) assay and cloning
The ChIP assay for the purpose of cloning immunoprecipitated
DNA fragments were performed as described recently using
modification described elsewhere [13,14]. Briefly, GRMO2 cells
were cultured to a confluency of 1  107 cells in 500 cm2 dish and
subjected to 8 h 0.5 mM 8-Br cAMP treatment. The cell pellets were
resuspended in 2.0 ml lysis buffer Incubate on ice for 10 min. Cells
were lysed (10 strokes) using an ice-cold dounce homogenizer.
Nuclei were pelleted using a microfuge at 5000 rpm for 10 min at
40 C. The nuclei pellet was resuspended in 2 ml nuclei lysis buffer
plus the same protease inhibitors as the cell lysis buffer and incu-
bated on ice for 10 min. Samples were processed a described in the
ChIP assay. After elution from protein A-beads, samples were
diluted using IP dilution buffer and subjected to another round of
immunoprecipitation followed by washing and elution. After the
second elution, the elutants were reverse cross-linked and the
chromatin sample was purified using Qiaquick PCR purification kit
(Qiagen), according to manufacture's protocol.
The Chromatin fragments were blunt-end repair and dephos-
phorylated using the TOPO Shotgun Subcloning Kit according to the
manufacture's instructions. The DNA was subjected to ligation-
mediated PCR (LMPCR), chromatin amplicon were generated by
20 cycles of PCR using the reported conditions [14], each reaction
was purified using the Qiaquick PCR purification kit. The PCR pro-
tocol was repeated (1, 2 or 3) until enough amplicon was
made. The resulting PCR products were cloned into PCR 2.1 TOPO
vector. DNA plasmids from the recombinant colonies were
screened by EcoRI digestion. EcoRI sites flank the PCR product
insertion sites for excision of inserts. Colonies with inserts greater
then 200 bps were sequenced using T7 primers. Obtained se-
quences were blasted against the mouse genome. Sequences were
also subjected to a transcription factor binding site search [15,16].
3. Results and discussion
3.1. ChIP analysis of genes potentially regulated by CREM/ICER
ICER has shown to be strongly induced in ovaries by exogenous
gonadotropins in immature rats and is transiently expressed in the
ovaries immediately after the preovulatory LH surge in adult
cycling rats [7]. Our lab and others have suggested a role for ICER in
ovarian function based on the observation that many FSH-
responsive genes are transcriptionally repressed after the LH
surge. We sought to perform a global analysis to map the binding
distribution of CREM/ICER along the entire mouse genome.
We opted to use a modification on the ChIP assay to clone DNA
associated with CREM/ICER as a means to directly identify candi-
date genes CREM/ICER could potentially regulate in the ovaries.
This approach has been successfully utilized previously to clone
novel E2F promoter targets [13]. Using a similar approach, we
cloned and sequenced the immunoprecipitated CREM/ICER-
associated DNAs from GRMO2 cells.
3.2. ChIP, target validation and amplification
The ChIP assay was performed with some modification as
described [13]. Chromatin was extracted from GRMO2 cells
Fig. 1. Validation and amplification of immunoprecipitated chromatin fragments.
GRMO2 cells were treated with 8-Br cAMP for 12 h to mimic the induced protein levels
of ICER seen during the preovulatory LH Surge. A. Representative ChIP analysis of
chromatin immunoprecipitated with either anti-ICER or pre-immune control rabbit
IgG. Following DNA purification, samples were PCR amplified using a pair of primers
covering the regions of Cyclin D2 and ICER gene promoter. B. Immunoprecipitated
chromatin was first repaired to make the amplicons blunt ended. The blunted chro-
matin fragments were ligated with unidirectional double stranded oligonucleotide
linkers. Chromatin amplicon were generated by 20 cycles of PCR and each reaction was
purified using the Qiaquick PCR purification kit. The PCR protocol was repeated (1,
2 and 3) until enough amplicon was made. Pictured is an ethidium bromide stained
gel with 5ul of the amplicon resolved on a 1% agarose gel, with fragments ranging
between 300bp to 1 kb.
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(1  107 cells) treated with 8-Br cAMP for 8 h. After the chromatin
was fixed and sheared, the samples were divided and either
immunoprecipitated with an antibody recognizing ICER or sub-
jected to pre-immune rabbit IgG as a negative control. To minimize
the occurrence of non-specific DNA carry-over, the immunopreci-
pated chromatinwas eluted from the protein A beads and subjected
to another round of immunoprecipitation. The assay was validated
by PCR using primers flanking the four CREs within the Crem in-
ternal promoter [5], as a positive control for ICER binding (Fig. 1A).
Since the PCR on the chromatin immunoprecipitated against ICER
resulted, as expected, in the amplification of the targeted promoter
regions, we next blunt-end repaired the sheared chromatin and
added to its ends unidirectional double stranded oligonucleotide
linkers. Chromatin amplicons were generated by 20 cycles of PCR
and each reaction was purified using the Qiaquick PCR purification
kit. The PCR protocol was repeated (1, 2 and 3) until enough
amplicon was made, producing a smear between 400bp to 3 kb
(Fig. 1B).
3.3. Sequencing and identity determination of immunoprecipitated
DNA
The resulting amplified chromatin was subcloned into a pCR II -
Topo vector. DNA extracted from the recombinant colonies were
screened by EcoRI digestion and plasmids with inserts greater then
200bp were sequenced using T7 primers (Fig. 2A). The different
DNA sequences obtained were screened against the mouse genome
using the NCBI-BLAST program for mouse sequences (Fig. 2B). The
DNA sequences were also subjected to a transcription factor bind-
ing site search using transcription factor search programs:
TFSEARCH [15], TESS [16] and the CREB Target Gene Database [17].
Fig. 2. Genes immunoprecipitated. A. PCR products were cloned directly into pCR II-TOPO vector and transformed into TOP10 competent cells. DNA mini-preps of the recombinant
colonies were screened by EcoRI digestion. EcoRI sites flank the PCR product insertion sites for excision of inserts. Colonies with inserts greater then 200 bps were sequenced busing
T7 primers. Obtained sequences were blasted against the mouse genome. Sequences were also subjected to a transcription factor binding site search. B. Representative list of the 70
sequenced clones. This list identifies the gene, location within the genomic DNA and chromosome number of the immunoprecipitated DNA fragment.
Fig. 3. Relative distribution of the immunoprecipitated chromatin fragments
throughout the mouse genome.
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We next examined the positions of the CREM/ICER binding
fragments relative to annotated exons and introns. As summarized
from the multiple categories shown in Fig. 3, 6% of the immuno-
precipitated regions (4 fragments) lay within 20 kb of the 50 end of
the gene, and 31% (22 fragments) of the CREM/ICER binding regions
lay within an intron. The 6% CREM/ICER binding fragments (4
fragments) intersected an annotated exon/intron region. Fig. 2B
reports a representative list of the 70 sequenced clones. Only 16% of
the CREM/ICER binding regions lay within a promoter relatively
adjacent to a TATA sequence. Our data is consistent with those
previously published, demonstrating that only a modest percent-
age of CREB sites were found near or within genes along human
chromosome 22 [18].
The use of ChIP has served as a valuable tool in identifying in vivo
binding of trans-acting factors binding to cis-elements on chro-
matin. Recently, researchers have begun using ChIP as an unbiased
approach to globally identify a target gene. For example, modifi-
cation of the ChIP assay has led to the discovery of novel E2F
binding sites by cloning of immunoprecipitated fragments [13]. We
employed this technique in our studies to globally identify CREM/
ICER binding sites throughout the mouse genome. Our data sup-
ports previous findings demonstrating that CREB binds to multiple
loci on human chromosome 22 [18]. However in that report, the
immunoprecipitated chromatin was hybridized to a genomic DNA
microarray containing all of the nonrepetitive DNA sequences of
human chromosome 22. Their data demonstrated that only a small
fraction of CREB binding sites lay near the well-defined 50 ends of
genes. Instead, the majority of sites were found within introns and
unannotated regions. Similar results were obtained in our studies
where we directly cloned and sequenced CREM/ICER targets. Their
data also demonstrated that few CREB targets were found near full-
length cyclic AMP response element sites, the majority of the CREB
targets contained shorter versions or close matches to this
sequence. Although the expression of CREB and CREM is believed to
be ubiquitous, the dogma of constitutive occupancy of a CRE has
been challenged. Several studies have demonstrated that CREB
binding is highly tissue-specific and such binding were apparent at
genes that were transcriptionally active but not on promoters of
genes that were not expressed [19].
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